Published in

Taylor and Francis Group, Expert Review of Hematology, 5(11), p. 423-435, 2018

DOI: 10.1080/17474086.2018.1456331

Links

Tools

Export citation

Search in Google Scholar

Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapy

Journal article published in 2018 by Elena Zamagni ORCID, Paola Tacchetti, Lucia Pantani, Michele Cavo ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO